Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction while Wilson Sonsini represented Amprius Technologies. Kensington Capital Acquisition Corp. IV executed its business...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed represented Cenveo in the transaction while O’Melveny represented Brook + Whittle. Brook + Whittle, a leading provider of pressure sensitive and shrink...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz acted as legal advisor to Santander Holdings USA, Inc. in the transaction. Hughes Hubbard acted as legal counsel to Santander Consumer...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison LLP advised Bowlero. Davis Polk advised Atairos, a significant current holder of Bowlero’s equity. Proskauer acted as legal advisor to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Loyens & Loeff represented Wallbox, while Cuatrecasas, Hughes Hubbard & Reed and Houthoff represented Kensington Capital Acquisition Corp. II in the...
You must be a Standard 1 Year member to access this content.
